Table 1. Patient Characteristics.
Characteristic | Patients, No. (%) | |
---|---|---|
Laparotomy arm (nā=ā51) | MIS arm (nā=ā49) | |
Age, median (IQR), y | 63 (57-70) | 61 (55-68) |
Racea | ||
Asian | 1 (2) | 3 (6) |
Black or African American | 3 (6) | 0 |
White | 46 (90) | 44 (90) |
Otherb | 1 (2) | 2 (4) |
Ethnicitya | ||
Hispanic or Latino | 15 (29) | 18 (37) |
Not Hispanic or Latino | 36 (71) | 31 (63) |
Primary tumor | ||
Ovary | 40 (78) | 42 (86) |
Fallopian tube | 2 (4) | 0 |
Peritoneum | 9 (18) | 7 (14) |
Histologic type | ||
Serous | 48 (94) | 46 (94) |
Other high-grade adenocarcinomas | 3 (6) | 1 (2) |
Unknown | 0 | 2 (4) |
Preoperative BRCA status | ||
Wild type | 25 (49) | 25 (51) |
BRCA1 mutated | 5 (10) | 3 (6) |
BRCA2 mutated | 3 (6) | 6 (12) |
Unknown | 18 (35) | 15 (30) |
Cancer stage | ||
IIIC | 34 (67) | 33 (67) |
IVA | 8 (16) | 9 (18) |
IVB | 9 (17) | 7 (15) |
MIS approach | ||
Traditional laparoscopy | NA | 48 (98) |
Robotic | NA | 1 (2) |
Planned HIPEC | ||
No | 40 (78) | 40 (82) |
Yes | 11 (22) | 9 (18) |
Surgical complexity score, median (IQR) | 2 (1-3) | 2 (1-3) |
Abbreviations: HIPEC, hyperthermic intraperitoneal chemotherapy; MIS, minimally invasive surgery; NA, not applicable.
Race and ethnicity were self-reported by patients.
Other category included unknown.